Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial

References

• Koes BW, van Tulder MW, Thomas S. Diagnosis and treatment of low back pain. BMJ 2006;332:1430-34
   PubMed Web of Science ®Google Scholar
• Krismer M, van Tulder M. The low Back Pain Group of the Bone and Joint, Health Strategies for Europe Project. Strategies for prevention and management of musculoskeletal conditions. Low back pain (non-specific). Best Pract Res Clin Rheumatol 2007;21:77-91
   PubMed Web of Science ®Google Scholar
• Schmidt CO, Raspe H, Pfingsten M, et al. Back pain in the German adult population: prevalence, severity, and sociodemographic correlates in a multiregional survey. Spine 2007;32:2005-11
   PubMed Web of Science ®Google Scholar
• Bigos S, Bowyer O, Braen G, et al. Acute low back problems in adults. Clinical practice guideline no. 14. AHCPR publication no. 95-0642. Rockville, Md.: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, 1994
   Google Scholar
• Chou R, Huffman LH, American Pain Society, American College of Physicians. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007;147:505-14
   PubMed Web of Science ®Google Scholar
• Argoff CE. Pharmacologic management of chronic pain. J Am Osteopath Assoc 2002;102 (Suppl. 3):S21-27
   PubMedGoogle Scholar
• Kornhuber J, Bleich S, Wiltfang J, et al. Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication. J Neural Transm 1999;106:857-67
   PubMed Web of Science ®Google Scholar
• Friedel HA, Fitton A. Flupirtine: a review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs 1993;45:548-69
   PubMed Web of Science ®Google Scholar
• Wörz R, Bolten W, Heller B, et al. Flupirtin im Vergleich zu Chlormezanon und Plazebo bei chronischen muskuloskelettalen Rückenschmerzen. Fortschr Med 1996;114:46-50
   Google Scholar
• Sitzer G. Einfachblindstudie mit Flupirtin gegen Acetylsalicylsäure bei Patienten mit spinalem Wurzelreizsyndrom. Orthopädie/Traumatol 1991;6:37-44
   Google Scholar
• Kamchatnov PR, Btysheva TT, Ganzhula PA, et al. [The use of katadolon in patients with spondylogenic dorsalgia]. Zh Nevrol Psikhiatr Im S S Korsakova 2006;106:46-8
   PubMedGoogle Scholar
• Müller-Schwefe G. Flupirtin bei muskuloskelettalen Schmerzen. Fortschr Med 2003;121:11-18
   Google Scholar
• Müller-Schwefe GHH, Überall MA. Analgetische und muskeltonus-normalisierende Wirkung von Flupirtin retard bei chronischen Rückschmerzen. Ergebnisse einer standardisierten Therapieevaluation unter Verwendung objektiver Verfahren zur Messung von Druckschmerzschwelle, Druckschmerztoleranz und Muskelspannung. MMW Fortschr Med 2008;149 (Suppl. 4):153-61
   Google Scholar
• Lüben V, Müller H, Lobisch M, et al. Behandlung von Tumorschmerzen mit Flupirtin – Ergebnisse einer Doppelblindstudie versus Tramadol. Fortschr Med 1994;112:282-6
   PubMedGoogle Scholar
• Martell BA, O’Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146:116-27
   PubMed Web of Science ®Google Scholar
• Schug SA. The role of tramadol in current treatment strategies for musculoskeletal pain. Ther Clin Risk Manag 2007;3:717-23
   PubMedGoogle Scholar
• Zerbini C, Ozturk ZE, Grifka J, et al. Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study. Curr Med Res Opin 2005;21:2037-49
   PubMed Web of Science ®Google Scholar
• Pallay RM, Seger W, Adler JL, et al. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol. 2004;33:257-66
   PubMed Web of Science ®Google Scholar
• Katz N, Ju WD, Krupa DA, et al. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials. Spine 2003;28:851-8
   PubMed Web of Science ®Google Scholar
• Ehrich EW, Davies GM, Watson DJ, et al. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000;27:2635-41
   PubMed Web of Science ®Google Scholar
• Perrot S, Krause D, Crozes P, et al. Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment study. Clin Ther 2006;28:1592-606
   PubMed Web of Science ®Google Scholar
• Schnitzer TJ, Gray WL, Paster RZ, et al. Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol 2000;27:772-8
   PubMed Web of Science ®Google Scholar
• Überall MA. Flupirtin im Vergleich zu Chlormezanon und Plazebo bei chronischen muskuloskelettalen Rückenschmerzen – biometrische und methodische Re-Evaluation der Ergebnisse einer multizentrischen randomisierten Doppelblindstudie (unpublished)
   Google Scholar
• Ruoff GE. Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy 1999;19:88-93
   PubMed Web of Science ®Google Scholar
• Petrone D, Kamin M, Olson W. Slowing the titration rate of tramadol HCl reduces the incidence of discontinuation due to nausea and/or vomiting: a double-blind randomized trial. J Clin Pharm Ther 1999;24:115-23
   PubMed Web of Science ®Google Scholar
• Devogelaer JP, Dreiser RL, Abadie E, et al. Guidelines for clinical studies assessing the efficacy of drugs for the management of acute low back pain. Clin Exp Rheumatol 2003;21:691-4
   PubMed Web of Science ®Google Scholar
• Poiraudeau S, Rannou F, Le Henanff A, et al. Outcome of subacute low back pain: influence of patients’ and rheumatologists’ characteristics. Rheumatology 2006;45:718-23
   PubMed Web of Science ®Google Scholar
• Wong EY, Deyo RA. Acute low back pain. Prim Care Update for OB/GYNS 2001;8:171-4
   Google Scholar
• Kohlmann T. Bevölkerungsbezogene Epidemiologie am Beispiel chronischer Rückenschmerzen. In: Zenz M, Jurna I (eds.): Lehrbuch der Schmerztherapie. WVG Stuttgart, 2001, pp. 221-9
   Google Scholar